Larvol Delta - CytoImmune-Therapeutics-and-City-of-Hope-Announce-First-Patient-Dosed-in-a-Phase-1-Trial-Evaluating-a-Novel-OfftheShelf-Engineered-Natural-Killer-Cellular-Therapy-for-the-Treatment-of-NonSmall-Cell-Lung-Cancer

CYTO NK-102 - CytoImmune

https://www.businesswire.com/news/home/20220728005134/en/CytoImmune-Therapeutics-and-City-of-Hope-Announce-First-Patient-Dosed-in-a-Phase-1-Trial-Evaluating-a-Novel-Off-the-Shelf-Engineered-Natural-Killer-Cellular-Therapy-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer

Jul 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next